Mapping histology to metabolism: Coregistration of stained whole-brain sections to premortem PET in Alzheimer's disease

NeuroImage

Volumn 5, Issue 2, 1997, Pages 147-153

  Mega, Michael S ^a,b   Chen, Sylvia S ^a   Thompson, Paul M ^a   Woods, Roger P ^a   Karaca, Timur J ^a   Tiwari, Abhishek ^a   Vinters, Harry V ^b   Small, Gary W ^b   Toga, Arthur W ^a,b  

^a Division of Brain Mapping   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CASE REPORT; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0031074962     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.1996.0255     Document Type: Article

References (32)

1. Arnold S. E., Hyman B. T. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex. 1:1991;103-116.
2. 18D. J. Nucl. Med. 22:1981;372-375.
3. Berg L. Clinical dementia rating. Psychopharmacol. Bull. 24:1988;637-639.
4. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
5. De Leon M. J., George A. E. Regional correlation of PET and CT in senile dementia of the Alzheimer type. Am. J. Neuroradiol. 4:1983;553-556.
6. Duara R., Grady C. L. Positron emission tomography in Alzheimer's disease. Neurology. 36:1986;879-887.
7. Ferris S. H., De Leon M. J. Positron emission tomography in dementia. Adv. Neurol. 38:1983;123-129.
8. Foster N. L., Chase T. N. Alzheimer's disease: Focal cortical changes shown by positron emission tomography. Neurology. 33:1983;961-965.
9. 18. J. Comput. Assist. Tomogr. 7:1983;590-598.
10. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 19:1971;1-8.
11. Ginsberg M. D., Dietrich W. D. Coupled forebrain increases of local cerebral glucose utilization and blood flow during physiologic stimulation of a somatosensory pathway in the rat: Demonstration by double-label autoradiography. Neurology. 37:1987;11-19.
12. Grady C. L., Haxby J. V. Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology. 36:1986;1390-1392.
13. Grady C. L., Haxby J. V. Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia. 25:1987;807-816.
14. Hand P., Greenberg J. A normal and developmentally-altered cortical column: A laminar analysis of local glucose utilization with natural stimulation of a single receptor organ. Acta Neurol. Scand. 60:1979;46-47.
15. Haxby J. V., Grady C. L. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47:1990;753-760.
16. Huang S. C., Phelps M. E. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am. J. Physiol. 238:1980;E69-82.
17. Hughes C. P., Berg L. A new clinical scale for the staging of dementia. Br. J. Psychiatry. 140:1982;566-572.
18. Kadekaro M., Crane A. M. Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc. Natl. Acad. Sci. 82:1985;6010-6013.
19. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
20. McGeer P. L., Kamo H. Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer disease. Neurology. 36:1986;1569-1574.
21. McKhann G., Drachman D. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group, Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
22. Meyer J. S., Obara K. Diaschisis. Neurol. Res. 15:1993;362-366.
23. Mirra S. S., Hart M. N. Making the diagnosis of Alzheimer's disease - A primer for practicing neuropathologists. Arch. Pathol. Lab. Med. 117:1993;132-144.
24. Phelps M. E., Huang S. C. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxyglucose: Validation of method. Ann. Neurol. 6:1979;371-388.
25. 18. Circ. Res. 44:1979;127-137.
26. Salmon E., Franck G. Positron emission tomographic study in Alzheimer's disease and Pick's disease. Arch. Gerontol. Geriatr. 1:1989;241-247.
27. Samuel W., Terry R. D. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer's disease. Arch. Neurol. 51:1993;772-778.
28. Siegel S., Dahlbom M. Implementation and evaluation of a calculated attenuation correction for PET. IEEE Trans. Neurol. Sci. 39:1992;1117-1121.
29. Terry R. D., Hansen L. A. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangle. J. Neuropathol. Exp. Neurol. 46:1987;262-268.
30. Thompson P. M., Toga A. W. A surface-based technique for warping three dimensional images of the brain. IEEE Trans. Med. Imaging. 15:1996;1-16.
31. Toga A. W., Ambach K. L. High-resolution anatomy fromin situ. NeuroImage. 1:1994;334-344.
32. Woods R. P., Mazziotta J. C. MRI-PET registration with automated algorithm. J. Comput. Assist. Tomogr. 17:1993;536-546.